← Back to Clinical Trials
Recruiting NCT05210764

NCT05210764 General Anesthetics-related Changes in Prefrontal EEG During Pediatric Surgical Anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05210764
Status Recruiting
Phase
Sponsor Peking University First Hospital
Condition General Anesthetic
Study Type OBSERVATIONAL
Enrollment 366 participants
Start Date 2022-06-01
Primary Completion 2026-03

Eligibility & Interventions

Sex All sexes
Min Age 1 Minute
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
propofolsevofluraneS-ketamine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 366 participants in total. It began in 2022-06-01 with a primary completion date of 2026-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The change profiles of indices derived from pEEG such as phase-amplitude coupling and bicoherence based on individual general anesthetics in children have not been examined in previous literature. Whether those indices have the abilities to predict individual drug-related anesthesia depth in children need to be explored.

Eligibility Criteria

Inclusion Criteria: * patients aged 0-18 years, American Society of Anesthesiologists Physical Status I-II, scheduled for elective surgery in Peking University First Hospital. Exclusion Criteria: * Preterm patients; * Height and weight not within the standard ranges for respective ages; * Surgery for head or heart; * Patients with muscular, neurologic or psychiatric diseases; * Patients with Congenital anomaly or hereditary diseases; * Patients with medication abuse; * Allergy to medication including propofol, sevoflurane, and ketamine; * Allergy to beans; * Refusal to participate the study by guardians.

Contact & Investigator

Central Contact

Linlin Song, MD

✉ songlinlinlynkia@163.com

📞 86-13501309217

Principal Investigator

Dong-Xin Wang, MD, PhD

STUDY DIRECTOR

Peking University First Hospital

Frequently Asked Questions

Who can join the NCT05210764 clinical trial?

This trial is open to participants of all sexes, aged 1 Minute or older, up to 18 Years, studying General Anesthetic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05210764 currently recruiting?

Yes, NCT05210764 is actively recruiting participants. Contact the research team at songlinlinlynkia@163.com for enrollment information.

Where is the NCT05210764 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT05210764 clinical trial?

NCT05210764 is sponsored by Peking University First Hospital. The principal investigator is Dong-Xin Wang, MD, PhD at Peking University First Hospital. The trial plans to enroll 366 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology